Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1092

1.

DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.

Kim IS, Kim DC, Kim HG, Eom HS, Kong SY, Shin HJ, Hwang SH, Lee EY, Kim S, Lee GW.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):31-7. doi: 10.1016/j.cancergencyto.2009.08.008.

PMID:
19963133
[PubMed - indexed for MEDLINE]
2.

Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.

Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, Kitpoka P, Thithapandha A, Hongeng S.

Pediatr Blood Cancer. 2007 Jan;48(1):16-20.

PMID:
16435384
[PubMed - indexed for MEDLINE]
3.

ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy.

Kim IS, Kim HG, Kim DC, Eom HS, Kong SY, Shin HJ, Hwang SH, Lee EY, Lee GW.

Cancer Sci. 2008 Dec;99(12):2496-501. doi: 10.1111/j.1349-7006.2008.00985.x. Epub 2008 Nov 20.

PMID:
19032367
[PubMed - indexed for MEDLINE]
4.

Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.

Park YH, Sohn SK, Kim JG, Lee MH, Song HS, Kim MK, Jung JS, Lee JJ, Kim HJ, Kim DH.

Clin Cancer Res. 2009 Mar 15;15(6):2107-15. doi: 10.1158/1078-0432.CCR-08-1588. Epub 2009 Mar 10.

PMID:
19276283
[PubMed - indexed for MEDLINE]
Free Article
5.

Genetic polymorphisms of XRCC1 and risk of gastric cancer.

Lee SG, Kim B, Choi J, Kim C, Lee I, Song K.

Cancer Lett. 2002 Dec 10;187(1-2):53-60.

PMID:
12359351
[PubMed - indexed for MEDLINE]
6.

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.

Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK; Lymphoma Study Division of the Korean Cancer Study Group.

Ann Hematol. 2006 Apr;85(4):257-62. Epub 2006 Jan 17.

PMID:
16416337
[PubMed - indexed for MEDLINE]
7.

Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.

Sar A, Perizzolo M, Stewart D, Mansoor A, Difrancesco LM, Demetrick DJ.

Leuk Res. 2009 Jun;33(6):792-7. doi: 10.1016/j.leukres.2008.10.013. Epub 2008 Dec 2.

PMID:
19054557
[PubMed - indexed for MEDLINE]
8.
9.

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma.

Kim DH, Jung HD, Kim JG, Lee JJ, Yang DH, Park YH, Do YR, Shin HJ, Kim MK, Hyun MS, Sohn SK.

Blood. 2006 Oct 15;108(8):2720-5. Epub 2006 Apr 11.

PMID:
16609067
[PubMed - indexed for MEDLINE]
Free Article
10.

Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.

Srivastava A, Srivastava K, Pandey SN, Choudhuri G, Mittal B.

Ann Surg Oncol. 2009 Jun;16(6):1695-703. doi: 10.1245/s10434-009-0354-3. Epub 2009 Mar 6.

PMID:
19266243
[PubMed - indexed for MEDLINE]
11.

[Correlations of single nucleotide polymorphisms of DNA repair gene XRCC1 to risk of colorectal cancer].

Jin MJ, Chen K, Zhang Y, Zhang W, Liu B, Zhang YJ.

Ai Zheng. 2007 Mar;26(3):274-9. Chinese.

PMID:
17355790
[PubMed - indexed for MEDLINE]
12.

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N, O'Reilly S, Spinelli JJ, Sutherland J, Wilson KS, Gascoyne RD, Connors JM.

J Clin Oncol. 2005 Aug 1;23(22):5027-33. Epub 2005 Jun 13.

PMID:
15955905
[PubMed - indexed for MEDLINE]
13.

Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma.

Cho HJ, Eom HS, Kim HJ, Kim IS, Lee GW, Kong SY.

Cancer Genet Cytogenet. 2010 Apr 1;198(1):40-6. doi: 10.1016/j.cancergencyto.2009.12.004.

PMID:
20303013
[PubMed - indexed for MEDLINE]
14.

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.

Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P, Horsman DE, Gascoyne RD.

Blood. 2009 Oct 22;114(17):3533-7. doi: 10.1182/blood-2009-05-220095. Epub 2009 Aug 24.

PMID:
19704118
[PubMed - indexed for MEDLINE]
Free Article
15.

The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.

Nishimori H, Matsuo K, Maeda Y, Nawa Y, Sunami K, Togitani K, Takimoto H, Hiramatsu Y, Kiguchi T, Yano T, Yamane H, Tabayashi T, Takeuchi M, Makita M, Sezaki N, Yamasuji Y, Sugiyama H, Tabuchi T, Kataoka I, Fujii N, Ishimaru F, Shinagawa K, Ikeda K, Hara M, Yoshino T, Tanimoto M; West-Japan Hematology and Oncology Group.

Int J Hematol. 2009 Apr;89(3):326-31. doi: 10.1007/s12185-009-0259-8. Epub 2009 Mar 27.

PMID:
19326060
[PubMed - indexed for MEDLINE]
16.

[Results of immuno-chemotherapeutic treatment of patients with diffuse large B-cell lymphoma].

Schneider T, Molnár Z, Deák B, Várady E, Tóth E, Csomor J, Matolcsy A, Lovey J, Lengyel Z, Petri K, Gaudi I, Rosta A.

Orv Hetil. 2009 Nov 1;150(44):2019-26. doi: 10.1556/OH.2009.28726. Hungarian.

PMID:
19861288
[PubMed - indexed for MEDLINE]
Free Article
17.

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.

J Clin Oncol. 2008 Oct 1;26(28):4587-94. doi: 10.1200/JCO.2007.15.9277. Epub 2008 Jul 28.

PMID:
18662967
[PubMed - indexed for MEDLINE]
18.

XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.

Schneider J, Classen V, Bernges U, Philipp M.

Int J Mol Med. 2005 Oct;16(4):709-16.

PMID:
16142409
[PubMed - indexed for MEDLINE]
19.

Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients.

Ahn HK, Kim SJ, Yun J, Yi JH, Kim JH, Won YW, Kim K, Ko YH, Kim WS.

Int J Hematol. 2010 Apr;91(3):456-63. doi: 10.1007/s12185-010-0536-6. Epub 2010 Mar 3.

PMID:
20198460
[PubMed - indexed for MEDLINE]
20.

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.

Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R.

J Cancer Res Clin Oncol. 2008 Jun;134(6):645-52. Epub 2007 Oct 19.

PMID:
17952468
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk